Stock Taper
BACK
IMAC HOLDINGS, INC.
OTC
$0.00
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$1.89 K
52w High$0.21
52w Low$0.00
Dividend Yield
Frequency
P/E
Volume200
Shares Out.3.78M

COMPANY

LEADERSHIP

Faith Zaslavsky
CHIEF EXECUTIVE
Faith Zaslavsky

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 13, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
15

UPCOMING EARNINGS

DateAug 31, 2026
DayMonday
Rev. Est.
AUG
31
MON

SPLIT RECORD

DATETYPERATIO
2023-09-08Reverse1:30

PRICE

$0.00 ▲ UP 0.00% (+$0.00)
OVERLAYS
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.009:31 AM9:31 AM9:31 AM9:31 AM9:31 AM9:31 AM9:32 AM0.00

About IMAC Holdings, Inc.

https://imacregeneration.gcs-web.com ↗

IMAC Holdings, Inc. operates 15 outpatient clinics across the U.S. offering regenerative, orthopedic, minimally invasive treatments, physical therapy, and chiropractic care for sports injuries, joint pain, and soft tissue conditions.

INDUSTRY

Medical - Care Facilities

A SERVICE IMAC HOLDINGS, INC. IS KNOWN FOR

Reverse Phase Protein Array (RPPA) Platform

IMAC Holdings, via Ignite Proteomics, provides a platform to quantify protein signaling, aiding oncologists in targeted cancer treatments and advancing the company's focus on precision oncology.

Revenue by Products

IconPRODUCTQ1-2021Q1-2025Q2-2025
Patient Revenues$3.02M
Operating Segments$103.19K $102.33K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

SECTORS PEERS

PEERPRICE
PRE$25.76COMPARE
PIII$9.22COMPARE
ACON$2.40COMPARE
DRMA$1.34COMPARE
CERO$0.01COMPARE
OCEA$0.00COMPARE
PPBT$1.68COMPARE
NUWE$0.89COMPARE